Skip to main content
Top
Published in: Journal of Neuroinflammation 1/2014

Open Access 01-12-2014 | Research

Diet-induced obesity and low testosterone increase neuroinflammation and impair neural function

Authors: Anusha Jayaraman, Daniella Lent-Schochet, Christian J Pike

Published in: Journal of Neuroinflammation | Issue 1/2014

Login to get access

Abstract

Background

Low testosterone and obesity are independent risk factors for dysfunction of the nervous system including neurodegenerative disorders such as Alzheimer’s disease (AD). In this study, we investigate the independent and cooperative interactions of testosterone and diet-induced obesity on metabolic, inflammatory, and neural health indices in the central and peripheral nervous systems.

Methods

Male C57B6/J mice were maintained on normal or high-fat diet under varying testosterone conditions for a four-month treatment period, after which metabolic indices were measured and RNA isolated from cerebral cortex and sciatic nerve. Cortices were used to generate mixed glial cultures, upon which embryonic cerebrocortical neurons were co-cultured for assessment of neuron survival and neurite outgrowth. Peripheral nerve damage was determined using paw-withdrawal assay, myelin sheath protein expression levels, and Na+,K+-ATPase activity levels.

Results

Our results demonstrate that detrimental effects on both metabolic (blood glucose, insulin sensitivity) and proinflammatory (cytokine expression) responses caused by diet-induced obesity are exacerbated by testosterone depletion. Mixed glial cultures generated from obese mice retain elevated cytokine expression, although low testosterone effects do not persist ex vivo. Primary neurons co-cultured with glial cultures generated from high-fat fed animals exhibit reduced survival and poorer neurite outgrowth. In addition, low testosterone and diet-induced obesity combine to increase inflammation and evidence of nerve damage in the peripheral nervous system.

Conclusions

Testosterone and diet-induced obesity independently and cooperatively regulate neuroinflammation in central and peripheral nervous systems, which may contribute to observed impairments in neural health. Together, our findings suggest that low testosterone and obesity are interactive regulators of neuroinflammation that, in combination with adipose-derived inflammatory pathways and other factors, increase the risk of downstream disorders including type 2 diabetes and Alzheimer’s disease.
Appendix
Available only for authorised users
Literature
1.
go back to reference Morley JE: Androgens and aging. Maturitas. 2001, 38: 61-71. Discussion 71-73PubMed Morley JE: Androgens and aging. Maturitas. 2001, 38: 61-71. Discussion 71-73PubMed
2.
go back to reference Kaufman JM, Vermeulen A: The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev. 2005, 26: 833-876.PubMed Kaufman JM, Vermeulen A: The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev. 2005, 26: 833-876.PubMed
3.
go back to reference Holland J, Bandelow S, Hogervorst E: Testosterone levels and cognition in elderly men: a review. Maturitas. 2011, 69: 322-337.PubMed Holland J, Bandelow S, Hogervorst E: Testosterone levels and cognition in elderly men: a review. Maturitas. 2011, 69: 322-337.PubMed
4.
go back to reference Janowsky JS: The role of androgens in cognition and brain aging in men. Neuroscience. 2006, 138: 1015-1020.PubMed Janowsky JS: The role of androgens in cognition and brain aging in men. Neuroscience. 2006, 138: 1015-1020.PubMed
5.
go back to reference Rosario ER, Carroll JC, Oddo S, LaFerla FM, Pike CJ: Androgens regulate the development of neuropathology in a triple transgenic mouse model of Alzheimer’s disease. J Neurosci. 2006, 26: 13384-13389.PubMed Rosario ER, Carroll JC, Oddo S, LaFerla FM, Pike CJ: Androgens regulate the development of neuropathology in a triple transgenic mouse model of Alzheimer’s disease. J Neurosci. 2006, 26: 13384-13389.PubMed
6.
go back to reference Benice TS, Raber J: Testosterone and dihydrotestosterone differentially improve cognition in aged female mice. Learn Mem. 2009, 16: 479-485.PubMedCentralPubMed Benice TS, Raber J: Testosterone and dihydrotestosterone differentially improve cognition in aged female mice. Learn Mem. 2009, 16: 479-485.PubMedCentralPubMed
7.
go back to reference Leranth C, Hajszan T, MacLusky NJ: Androgens increase spine synapse density in the CA1 hippocampal subfield of ovariectomized female rats. J Neurosci. 2004, 24: 495-499.PubMed Leranth C, Hajszan T, MacLusky NJ: Androgens increase spine synapse density in the CA1 hippocampal subfield of ovariectomized female rats. J Neurosci. 2004, 24: 495-499.PubMed
8.
go back to reference Pike CJ: Testosterone attenuates beta-amyloid toxicity in cultured hippocampal neurons. Brain Res. 2001, 919: 160-165.PubMed Pike CJ: Testosterone attenuates beta-amyloid toxicity in cultured hippocampal neurons. Brain Res. 2001, 919: 160-165.PubMed
9.
go back to reference Gadau S, Lepore G, Zedda M, Mura A, Farina V: Different nitrosative-induced microtubular modifications and testosterone neuroprotective effects on high-D-glucose-exposed neuroblastoma and glioma cells. Neuro Endocrinol Lett. 2009, 30: 515-524.PubMed Gadau S, Lepore G, Zedda M, Mura A, Farina V: Different nitrosative-induced microtubular modifications and testosterone neuroprotective effects on high-D-glucose-exposed neuroblastoma and glioma cells. Neuro Endocrinol Lett. 2009, 30: 515-524.PubMed
10.
go back to reference Moffat SD, Zonderman AB, Metter EJ, Kawas C, Blackman MR, Harman SM, Resnick SM: Free testosterone and risk for Alzheimer disease in older men. Neurology. 2004, 62: 188-193.PubMed Moffat SD, Zonderman AB, Metter EJ, Kawas C, Blackman MR, Harman SM, Resnick SM: Free testosterone and risk for Alzheimer disease in older men. Neurology. 2004, 62: 188-193.PubMed
11.
go back to reference Hogervorst E, Williams J, Budge M, Barnetson L, Combrinck M, Smith AD: Serum total testosterone is lower in men with Alzheimer’s disease. Neuro Endocrinol Lett. 2001, 22: 163-168.PubMed Hogervorst E, Williams J, Budge M, Barnetson L, Combrinck M, Smith AD: Serum total testosterone is lower in men with Alzheimer’s disease. Neuro Endocrinol Lett. 2001, 22: 163-168.PubMed
12.
go back to reference Hogervorst E, Combrinck M, Smith AD: Testosterone and gonadotropin levels in men with dementia. Neuro Endocrinol Lett. 2003, 24: 203-208.PubMed Hogervorst E, Combrinck M, Smith AD: Testosterone and gonadotropin levels in men with dementia. Neuro Endocrinol Lett. 2003, 24: 203-208.PubMed
13.
go back to reference Paoletti AM, Congia S, Lello S, Tedde D, Orru M, Pistis M, Pilloni M, Zedda P, Loddo A, Melis GB: Low androgenization index in elderly women and elderly men with Alzheimer’s disease. Neurology. 2004, 62: 301-303.PubMed Paoletti AM, Congia S, Lello S, Tedde D, Orru M, Pistis M, Pilloni M, Zedda P, Loddo A, Melis GB: Low androgenization index in elderly women and elderly men with Alzheimer’s disease. Neurology. 2004, 62: 301-303.PubMed
14.
go back to reference Rosario ER, Chang L, Stanczyk FZ, Pike CJ: Age-related testosterone depletion and the development of Alzheimer disease. JAMA. 2004, 292: 1431-1432.PubMed Rosario ER, Chang L, Stanczyk FZ, Pike CJ: Age-related testosterone depletion and the development of Alzheimer disease. JAMA. 2004, 292: 1431-1432.PubMed
15.
go back to reference Rosario ER, Chang L, Head EH, Stanczyk FZ, Pike CJ: Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer’s disease. Neurobiol Aging. 2011, 32: 604-613.PubMedCentralPubMed Rosario ER, Chang L, Head EH, Stanczyk FZ, Pike CJ: Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer’s disease. Neurobiol Aging. 2011, 32: 604-613.PubMedCentralPubMed
16.
go back to reference Melcangi RC, Magnaghi V, Galbiati M, Ghelarducci B, Sebastiani L, Martini L: The action of steroid hormones on peripheral myelin proteins: a possible new tool for the rebuilding of myelin?. J Neurocytol. 2000, 29: 327-339.PubMed Melcangi RC, Magnaghi V, Galbiati M, Ghelarducci B, Sebastiani L, Martini L: The action of steroid hormones on peripheral myelin proteins: a possible new tool for the rebuilding of myelin?. J Neurocytol. 2000, 29: 327-339.PubMed
17.
go back to reference Roglio I, Bianchi R, Giatti S, Cavaletti G, Caruso D, Scurati S, Crippa D, Garcia-Segura LM, Camozzi F, Lauria G, Melcangi RC: Testosterone derivatives are neuroprotective agents in experimental diabetic neuropathy. Cell Mol Life Sci. 2007, 64: 1158-1168.PubMed Roglio I, Bianchi R, Giatti S, Cavaletti G, Caruso D, Scurati S, Crippa D, Garcia-Segura LM, Camozzi F, Lauria G, Melcangi RC: Testosterone derivatives are neuroprotective agents in experimental diabetic neuropathy. Cell Mol Life Sci. 2007, 64: 1158-1168.PubMed
18.
go back to reference Hernandez-Mijares A, Garcia-Malpartida K, Sola-Izquierdo E, Banuls C, Rocha M, Gomez-Martinez MJ, Marmol R, Victor VM: Testosterone levels in males with type 2 diabetes and their relationship with cardiovascular risk factors and cardiovascular disease. J Sex Med. 2010, 7: 1954-1964.PubMed Hernandez-Mijares A, Garcia-Malpartida K, Sola-Izquierdo E, Banuls C, Rocha M, Gomez-Martinez MJ, Marmol R, Victor VM: Testosterone levels in males with type 2 diabetes and their relationship with cardiovascular risk factors and cardiovascular disease. J Sex Med. 2010, 7: 1954-1964.PubMed
19.
go back to reference Mathus-Vliegen EM: Prevalence, pathophysiology, health consequences and treatment options of obesity in the elderly: a guideline. Obes Facts. 2012, 5: 460-483.PubMed Mathus-Vliegen EM: Prevalence, pathophysiology, health consequences and treatment options of obesity in the elderly: a guideline. Obes Facts. 2012, 5: 460-483.PubMed
20.
go back to reference Hill JO, Bessesen D: What to do about the metabolic syndrome?. Arch Intern Med. 2003, 163: 395-397.PubMed Hill JO, Bessesen D: What to do about the metabolic syndrome?. Arch Intern Med. 2003, 163: 395-397.PubMed
21.
go back to reference Luchsinger JA: A work in progress: the metabolic syndrome. Sci Aging Knowledge Environ. 2006, 2006: pe19.PubMed Luchsinger JA: A work in progress: the metabolic syndrome. Sci Aging Knowledge Environ. 2006, 2006: pe19.PubMed
22.
go back to reference Makki K, Froguel P, Wolowczuk I: Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines. ISRN Inflamm. 2013, 2013: 139239.PubMedCentralPubMed Makki K, Froguel P, Wolowczuk I: Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines. ISRN Inflamm. 2013, 2013: 139239.PubMedCentralPubMed
23.
go back to reference Teerds KJ, de Rooij DG, Keijer J: Functional relationship between obesity and male reproduction: from humans to animal models. Hum Reprod Update. 2011, 17: 667-683.PubMed Teerds KJ, de Rooij DG, Keijer J: Functional relationship between obesity and male reproduction: from humans to animal models. Hum Reprod Update. 2011, 17: 667-683.PubMed
24.
go back to reference Yaffe K, Kanaya A, Lindquist K, Simonsick EM, Harris T, Shorr RI, Tylavsky FA, Newman AB: The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA. 2004, 292: 2237-2242.PubMed Yaffe K, Kanaya A, Lindquist K, Simonsick EM, Harris T, Shorr RI, Tylavsky FA, Newman AB: The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA. 2004, 292: 2237-2242.PubMed
25.
go back to reference Kivipelto M, Ngandu T, Fratiglioni L, Viitanen M, Kareholt I, Winblad B, Helkala EL, Tuomilehto J, Soininen H, Nissinen A: Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol. 2005, 62: 1556-1560.PubMed Kivipelto M, Ngandu T, Fratiglioni L, Viitanen M, Kareholt I, Winblad B, Helkala EL, Tuomilehto J, Soininen H, Nissinen A: Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol. 2005, 62: 1556-1560.PubMed
26.
go back to reference Kanaya AM, Lindquist K, Harris TB, Launer L, Rosano C, Satterfield S, Yaffe K: Total and regional adiposity and cognitive change in older adults: the health, aging and body composition (ABC) study. Arch Neurol. 2009, 66: 329-335.PubMedCentralPubMed Kanaya AM, Lindquist K, Harris TB, Launer L, Rosano C, Satterfield S, Yaffe K: Total and regional adiposity and cognitive change in older adults: the health, aging and body composition (ABC) study. Arch Neurol. 2009, 66: 329-335.PubMedCentralPubMed
27.
go back to reference Helzner EP, Luchsinger JA, Scarmeas N, Cosentino S, Brickman AM, Glymour MM, Stern Y: Contribution of vascular risk factors to the progression in Alzheimer disease. Arch Neurol. 2009, 66: 343-348.PubMedCentralPubMed Helzner EP, Luchsinger JA, Scarmeas N, Cosentino S, Brickman AM, Glymour MM, Stern Y: Contribution of vascular risk factors to the progression in Alzheimer disease. Arch Neurol. 2009, 66: 343-348.PubMedCentralPubMed
28.
go back to reference Williamson R, McNeilly A, Sutherland C: Insulin resistance in the brain: an old-age or new-age problem?. Biochem Pharmacol. 2012, 84: 737-745.PubMed Williamson R, McNeilly A, Sutherland C: Insulin resistance in the brain: an old-age or new-age problem?. Biochem Pharmacol. 2012, 84: 737-745.PubMed
29.
go back to reference Callaghan B, Feldman E: The metabolic syndrome and neuropathy: therapeutic challenges and opportunities. Ann Neurol. 2013, 74: 397-403.PubMed Callaghan B, Feldman E: The metabolic syndrome and neuropathy: therapeutic challenges and opportunities. Ann Neurol. 2013, 74: 397-403.PubMed
30.
go back to reference Kapoor D, Aldred H, Clark S, Channer KS, Jones TH: Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity. Diabetes Care. 2007, 30: 911-917.PubMed Kapoor D, Aldred H, Clark S, Channer KS, Jones TH: Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity. Diabetes Care. 2007, 30: 911-917.PubMed
31.
go back to reference Kupelian V, Hayes FJ, Link CL, Rosen R, McKinlay JB: Inverse association of testosterone and the metabolic syndrome in men is consistent across race and ethnic groups. J Clin Endocrinol Metab. 2008, 93: 3403-3410.PubMedCentralPubMed Kupelian V, Hayes FJ, Link CL, Rosen R, McKinlay JB: Inverse association of testosterone and the metabolic syndrome in men is consistent across race and ethnic groups. J Clin Endocrinol Metab. 2008, 93: 3403-3410.PubMedCentralPubMed
32.
go back to reference Stellato RK, Feldman HA, Hamdy O, Horton ES, McKinlay JB: Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care. 2000, 23: 490-494.PubMed Stellato RK, Feldman HA, Hamdy O, Horton ES, McKinlay JB: Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care. 2000, 23: 490-494.PubMed
33.
go back to reference Zou B, Sasaki H, Kumagai S: Association between relative hypogonadism and metabolic syndrome in newly diagnosed adult male patients with impaired glucose tolerance or type 2 diabetes mellitus. Metab Syndr Relat Disord. 2004, 2: 39-48.PubMed Zou B, Sasaki H, Kumagai S: Association between relative hypogonadism and metabolic syndrome in newly diagnosed adult male patients with impaired glucose tolerance or type 2 diabetes mellitus. Metab Syndr Relat Disord. 2004, 2: 39-48.PubMed
34.
go back to reference Grossmann M, Thomas MC, Panagiotopoulos S, Sharpe K, Macisaac RJ, Clarke S, Zajac JD, Jerums G: Low testosterone levels are common and associated with insulin resistance in men with diabetes. J Clin Endocrinol Metab. 2008, 93: 1834-1840.PubMed Grossmann M, Thomas MC, Panagiotopoulos S, Sharpe K, Macisaac RJ, Clarke S, Zajac JD, Jerums G: Low testosterone levels are common and associated with insulin resistance in men with diabetes. J Clin Endocrinol Metab. 2008, 93: 1834-1840.PubMed
35.
go back to reference Pitteloud N, Mootha VK, Dwyer AA, Hardin M, Lee H, Eriksson KF, Tripathy D, Yialamas M, Groop L, Elahi D, Hayes FJ: Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men. Diabetes Care. 2005, 28: 1636-1642.PubMed Pitteloud N, Mootha VK, Dwyer AA, Hardin M, Lee H, Eriksson KF, Tripathy D, Yialamas M, Groop L, Elahi D, Hayes FJ: Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men. Diabetes Care. 2005, 28: 1636-1642.PubMed
36.
go back to reference Chandel A, Dhindsa S, Topiwala S, Chaudhuri A, Dandona P: Testosterone concentration in young patients with diabetes. Diabetes Care. 2008, 31: 2013-2017.PubMedCentralPubMed Chandel A, Dhindsa S, Topiwala S, Chaudhuri A, Dandona P: Testosterone concentration in young patients with diabetes. Diabetes Care. 2008, 31: 2013-2017.PubMedCentralPubMed
37.
go back to reference Dhindsa S, Prabhakar S, Sethi M, Bandyopadhyay A, Chaudhuri A, Dandona P: Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. J Clin Endocrinol Metab. 2004, 89: 5462-5468.PubMed Dhindsa S, Prabhakar S, Sethi M, Bandyopadhyay A, Chaudhuri A, Dandona P: Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. J Clin Endocrinol Metab. 2004, 89: 5462-5468.PubMed
38.
go back to reference Allan CA, Strauss BJ, Burger HG, Forbes EA, McLachlan RI: Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men. J Clin Endocrinol Metab. 2008, 93: 139-146.PubMed Allan CA, Strauss BJ, Burger HG, Forbes EA, McLachlan RI: Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men. J Clin Endocrinol Metab. 2008, 93: 139-146.PubMed
39.
go back to reference Bhasin S, Parker RA, Sattler F, Haubrich R, Alston B, Umbleja T, Shikuma CM: Effects of testosterone supplementation on whole body and regional fat mass and distribution in human immunodeficiency virus-infected men with abdominal obesity. J Clin Endocrinol Metab. 2007, 92: 1049-1057.PubMed Bhasin S, Parker RA, Sattler F, Haubrich R, Alston B, Umbleja T, Shikuma CM: Effects of testosterone supplementation on whole body and regional fat mass and distribution in human immunodeficiency virus-infected men with abdominal obesity. J Clin Endocrinol Metab. 2007, 92: 1049-1057.PubMed
40.
go back to reference Shahani S, Braga-Basaria M, Basaria S: Androgen deprivation therapy in prostate cancer and metabolic risk for atherosclerosis. J Clin Endocrinol Metab. 2008, 93: 2042-2049.PubMed Shahani S, Braga-Basaria M, Basaria S: Androgen deprivation therapy in prostate cancer and metabolic risk for atherosclerosis. J Clin Endocrinol Metab. 2008, 93: 2042-2049.PubMed
41.
go back to reference Haidar A, Yassin A, Saad F, Shabsigh R: Effects of androgen deprivation on glycaemic control and on cardiovascular biochemical risk factors in men with advanced prostate cancer with diabetes. Aging Male. 2007, 10: 189-196.PubMed Haidar A, Yassin A, Saad F, Shabsigh R: Effects of androgen deprivation on glycaemic control and on cardiovascular biochemical risk factors in men with advanced prostate cancer with diabetes. Aging Male. 2007, 10: 189-196.PubMed
42.
go back to reference Keating NL, O’Malley AJ, Smith MR: Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. J Clin Oncol. 2006, 24: 4448-4456.PubMed Keating NL, O’Malley AJ, Smith MR: Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. J Clin Oncol. 2006, 24: 4448-4456.PubMed
43.
go back to reference Braga-Basaria M, Dobs AS, Muller DC, Carducci MA, John M, Egan J, Basaria S: Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy. J Clin Oncol. 2006, 24: 3979-3983.PubMed Braga-Basaria M, Dobs AS, Muller DC, Carducci MA, John M, Egan J, Basaria S: Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy. J Clin Oncol. 2006, 24: 3979-3983.PubMed
44.
go back to reference Singh M, Lin SQ, Saxena BB: Effect of immunization with lutropin-receptor on the ovarian function of rabbits. J Immunoassay. 1995, 16: 1-16.PubMed Singh M, Lin SQ, Saxena BB: Effect of immunization with lutropin-receptor on the ovarian function of rabbits. J Immunoassay. 1995, 16: 1-16.PubMed
45.
go back to reference Jayaraman A, Carroll JC, Morgan TE, Lin S, Zhao L, Arimoto JM, Murphy MP, Beckett TL, Finch CE, Brinton RD, Pike CJ: 17beta-estradiol and progesterone regulate expression of beta-amyloid clearance factors in primary neuron cultures and female rat brain. Endocrinology. 2012, 153: 5467-5479.PubMedCentralPubMed Jayaraman A, Carroll JC, Morgan TE, Lin S, Zhao L, Arimoto JM, Murphy MP, Beckett TL, Finch CE, Brinton RD, Pike CJ: 17beta-estradiol and progesterone regulate expression of beta-amyloid clearance factors in primary neuron cultures and female rat brain. Endocrinology. 2012, 153: 5467-5479.PubMedCentralPubMed
46.
go back to reference Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C(T)) Method. Methods. 2001, 25: 402-408.PubMed Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C(T)) Method. Methods. 2001, 25: 402-408.PubMed
47.
48.
go back to reference Bianchi R, Marini P, Merlini S, Fabris M, Triban C, Mussini E, Fiori MG: ATPase activity defects in alloxan-induced diabetic sciatic nerve recovered by ganglioside treatment. Diabetes. 1988, 37: 1340-1345.PubMed Bianchi R, Marini P, Merlini S, Fabris M, Triban C, Mussini E, Fiori MG: ATPase activity defects in alloxan-induced diabetic sciatic nerve recovered by ganglioside treatment. Diabetes. 1988, 37: 1340-1345.PubMed
49.
go back to reference Giatti S, Pesaresi M, Cavaletti G, Bianchi R, Carozzi V, Lombardi R, Maschi O, Lauria G, Garcia-Segura LM, Caruso D, Melcangi RC: Neuroprotective effects of a ligand of translocator protein-18 kDa (Ro5-4864) in experimental diabetic neuropathy. Neuroscience. 2009, 164: 520-529.PubMed Giatti S, Pesaresi M, Cavaletti G, Bianchi R, Carozzi V, Lombardi R, Maschi O, Lauria G, Garcia-Segura LM, Caruso D, Melcangi RC: Neuroprotective effects of a ligand of translocator protein-18 kDa (Ro5-4864) in experimental diabetic neuropathy. Neuroscience. 2009, 164: 520-529.PubMed
50.
go back to reference Canale MP, Manca Di Villahermosa S, Martino G, Rovella V, Noce A, De Lorenzo AD, Daniele N: Obesity-related metabolic syndrome: mechanisms of sympathetic overactivity. Int J Endocrinol. 2013, 2013: 865965.PubMedCentralPubMed Canale MP, Manca Di Villahermosa S, Martino G, Rovella V, Noce A, De Lorenzo AD, Daniele N: Obesity-related metabolic syndrome: mechanisms of sympathetic overactivity. Int J Endocrinol. 2013, 2013: 865965.PubMedCentralPubMed
51.
go back to reference Kapoor D, Jones TH: Androgen deficiency as a predictor of metabolic syndrome in aging men: an opportunity for intervention?. Drugs Aging. 2008, 25: 357-369.PubMed Kapoor D, Jones TH: Androgen deficiency as a predictor of metabolic syndrome in aging men: an opportunity for intervention?. Drugs Aging. 2008, 25: 357-369.PubMed
52.
go back to reference Corona G, Monami M, Rastrelli G, Aversa A, Tishova Y, Saad F, Lenzi A, Forti G, Mannucci E, Maggi M: Testosterone and metabolic syndrome: a meta-analysis study. J Sex Med. 2011, 8: 272-283.PubMed Corona G, Monami M, Rastrelli G, Aversa A, Tishova Y, Saad F, Lenzi A, Forti G, Mannucci E, Maggi M: Testosterone and metabolic syndrome: a meta-analysis study. J Sex Med. 2011, 8: 272-283.PubMed
53.
go back to reference Saad F, Gooren L: The role of testosterone in the metabolic syndrome: a review. J Steroid Biochem Mol Biol. 2009, 114: 40-43.PubMed Saad F, Gooren L: The role of testosterone in the metabolic syndrome: a review. J Steroid Biochem Mol Biol. 2009, 114: 40-43.PubMed
54.
go back to reference Cameron AJ, Magliano DJ, Soderberg S: A systematic review of the impact of including both waist and hip circumference in risk models for cardiovascular diseases, diabetes and mortality. Obes Rev. 2013, 14: 86-94.PubMed Cameron AJ, Magliano DJ, Soderberg S: A systematic review of the impact of including both waist and hip circumference in risk models for cardiovascular diseases, diabetes and mortality. Obes Rev. 2013, 14: 86-94.PubMed
55.
go back to reference Garber AJ: Obesity and type 2 diabetes: which patients are at risk?. Diabetes Obes Metab. 2012, 14: 399-408.PubMed Garber AJ: Obesity and type 2 diabetes: which patients are at risk?. Diabetes Obes Metab. 2012, 14: 399-408.PubMed
56.
go back to reference Stanworth RD, Jones TH: Testosterone in obesity, metabolic syndrome and type 2 diabetes. Front Horm Res. 2009, 37: 74-90.PubMed Stanworth RD, Jones TH: Testosterone in obesity, metabolic syndrome and type 2 diabetes. Front Horm Res. 2009, 37: 74-90.PubMed
57.
go back to reference Grossmann M, Gianatti EJ, Zajac JD: Testosterone and type 2 diabetes. Curr Opin Endocrinol Diabetes Obes. 2010, 17: 247-256.PubMed Grossmann M, Gianatti EJ, Zajac JD: Testosterone and type 2 diabetes. Curr Opin Endocrinol Diabetes Obes. 2010, 17: 247-256.PubMed
58.
go back to reference Davidson TL, Hargrave SL, Swithers SE, Sample CH, Fu X, Kinzig KP, Zheng W: Inter-relationships among diet, obesity and hippocampal-dependent cognitive function. Neuroscience. 2013, 253: 110-122.PubMedCentralPubMed Davidson TL, Hargrave SL, Swithers SE, Sample CH, Fu X, Kinzig KP, Zheng W: Inter-relationships among diet, obesity and hippocampal-dependent cognitive function. Neuroscience. 2013, 253: 110-122.PubMedCentralPubMed
59.
go back to reference Feng L, Chong MS, Lim WS, Lee TS, Collinson SL, Yap P, Ng TP: Metabolic syndrome and amnestic mild cognitive impairment: Singapore longitudinal ageing study-2 findings. J Alzheimers Dis. 2013, 34: 649-657.PubMed Feng L, Chong MS, Lim WS, Lee TS, Collinson SL, Yap P, Ng TP: Metabolic syndrome and amnestic mild cognitive impairment: Singapore longitudinal ageing study-2 findings. J Alzheimers Dis. 2013, 34: 649-657.PubMed
60.
go back to reference Maggio M, Dall’Aglio E, Lauretani F, Cattabiani C, Ceresini G, Caffarra P, Valenti G, Volpi R, Vignali A, Schiavi G, Ceda GP: The hormonal pathway to cognitive impairment in older men. J Nutr Health Aging. 2012, 16: 40-54.PubMed Maggio M, Dall’Aglio E, Lauretani F, Cattabiani C, Ceresini G, Caffarra P, Valenti G, Volpi R, Vignali A, Schiavi G, Ceda GP: The hormonal pathway to cognitive impairment in older men. J Nutr Health Aging. 2012, 16: 40-54.PubMed
61.
go back to reference Beauchet O: Testosterone and cognitive function: current clinical evidence of a relationship. Eur J Endocrinol. 2006, 155: 773-781.PubMed Beauchet O: Testosterone and cognitive function: current clinical evidence of a relationship. Eur J Endocrinol. 2006, 155: 773-781.PubMed
62.
go back to reference Zitzmann M: Testosterone deficiency, insulin resistance and the metabolic syndrome. Nat Rev Endocrinol. 2009, 5: 673-681.PubMed Zitzmann M: Testosterone deficiency, insulin resistance and the metabolic syndrome. Nat Rev Endocrinol. 2009, 5: 673-681.PubMed
63.
go back to reference Castro G, MF CA, Weissmann L, Quaresma PG, Katashima CK, Saad MJ, Prada PO: Diet-induced obesity induces endoplasmic reticulum stress and insulin resistance in the amygdala of rats. FEBS Open Bio. 2013, 3: 443-449.PubMedCentralPubMed Castro G, MF CA, Weissmann L, Quaresma PG, Katashima CK, Saad MJ, Prada PO: Diet-induced obesity induces endoplasmic reticulum stress and insulin resistance in the amygdala of rats. FEBS Open Bio. 2013, 3: 443-449.PubMedCentralPubMed
64.
go back to reference Davis DD, Ruiz AL, Yanes LL, Iliescu R, Yuan K, Moulana M, Racusen LC, Reckelhoff JF: Testosterone supplementation in male obese Zucker rats reduces body weight and improves insulin sensitivity but increases blood pressure. Hypertension. 2012, 59: 726-731.PubMedCentralPubMed Davis DD, Ruiz AL, Yanes LL, Iliescu R, Yuan K, Moulana M, Racusen LC, Reckelhoff JF: Testosterone supplementation in male obese Zucker rats reduces body weight and improves insulin sensitivity but increases blood pressure. Hypertension. 2012, 59: 726-731.PubMedCentralPubMed
65.
go back to reference Haffner SM, Shaten J, Stern MP, Smith GD, Kuller L: Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. MRFIT Research Group. Multiple Risk Factor Intervention Trial. Am J Epidemiol. 1996, 143: 889-897.PubMed Haffner SM, Shaten J, Stern MP, Smith GD, Kuller L: Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. MRFIT Research Group. Multiple Risk Factor Intervention Trial. Am J Epidemiol. 1996, 143: 889-897.PubMed
66.
go back to reference Goncharov NP, Katsya GV, Chagina NA, Gooren LJ: Testosterone and obesity in men under the age of 40 years. Andrologia. 2009, 41: 76-83.PubMed Goncharov NP, Katsya GV, Chagina NA, Gooren LJ: Testosterone and obesity in men under the age of 40 years. Andrologia. 2009, 41: 76-83.PubMed
67.
go back to reference Schroeder ET, Zheng L, Ong MD, Martinez C, Flores C, Stewart Y, Azen C, Sattler FR: Effects of androgen therapy on adipose tissue and metabolism in older men. J Clin Endocrinol Metab. 2004, 89: 4863-4872.PubMed Schroeder ET, Zheng L, Ong MD, Martinez C, Flores C, Stewart Y, Azen C, Sattler FR: Effects of androgen therapy on adipose tissue and metabolism in older men. J Clin Endocrinol Metab. 2004, 89: 4863-4872.PubMed
68.
go back to reference Kapoor D, Goodwin E, Channer KS, Jones TH: Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol. 2006, 154: 899-906.PubMed Kapoor D, Goodwin E, Channer KS, Jones TH: Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol. 2006, 154: 899-906.PubMed
69.
go back to reference Boyanov MA, Boneva Z, Christov VG: Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency. Aging Male. 2003, 6: 1-7.PubMed Boyanov MA, Boneva Z, Christov VG: Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency. Aging Male. 2003, 6: 1-7.PubMed
70.
go back to reference Hotamisligil GS: Inflammation and metabolic disorders. Nature. 2006, 444: 860-867.PubMed Hotamisligil GS: Inflammation and metabolic disorders. Nature. 2006, 444: 860-867.PubMed
71.
go back to reference Schmidt MI, Duncan BB, Sharrett AR, Lindberg G, Savage PJ, Offenbacher S, Azambuja MI, Tracy RP, Heiss G: Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet. 1999, 353: 1649-1652.PubMed Schmidt MI, Duncan BB, Sharrett AR, Lindberg G, Savage PJ, Offenbacher S, Azambuja MI, Tracy RP, Heiss G: Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet. 1999, 353: 1649-1652.PubMed
72.
go back to reference Donath MY, Shoelson SE: Type 2 diabetes as an inflammatory disease. Nat Rev Immunol. 2011, 11: 98-107.PubMed Donath MY, Shoelson SE: Type 2 diabetes as an inflammatory disease. Nat Rev Immunol. 2011, 11: 98-107.PubMed
73.
go back to reference Buckman LB, Hasty AH, Flaherty DK, Buckman CT, Thompson MM, Matlock BK, Weller K, Ellacott KL: Obesity induced by a high-fat diet is associated with increased immune cell entry into the central nervous system. Brain Behav Immun. 2014, 35: 33-42.PubMed Buckman LB, Hasty AH, Flaherty DK, Buckman CT, Thompson MM, Matlock BK, Weller K, Ellacott KL: Obesity induced by a high-fat diet is associated with increased immune cell entry into the central nervous system. Brain Behav Immun. 2014, 35: 33-42.PubMed
74.
go back to reference Cai D: Neuroinflammation and neurodegeneration in overnutrition-induced diseases. Trends Endocrinol Metab. 2013, 24: 40-47.PubMedCentralPubMed Cai D: Neuroinflammation and neurodegeneration in overnutrition-induced diseases. Trends Endocrinol Metab. 2013, 24: 40-47.PubMedCentralPubMed
75.
go back to reference Fung A, Vizcaychipi M, Lloyd D, Wan Y, Ma D: Central nervous system inflammation in disease related conditions: mechanistic prospects. Brain Res. 2012, 1446: 144-155.PubMed Fung A, Vizcaychipi M, Lloyd D, Wan Y, Ma D: Central nervous system inflammation in disease related conditions: mechanistic prospects. Brain Res. 2012, 1446: 144-155.PubMed
76.
go back to reference Cai D: NFkappaB-mediated metabolic inflammation in peripheral tissues versus central nervous system. Cell Cycle. 2009, 8: 2542-2548.PubMed Cai D: NFkappaB-mediated metabolic inflammation in peripheral tissues versus central nervous system. Cell Cycle. 2009, 8: 2542-2548.PubMed
77.
go back to reference Rampart M, De Smet W, Fiers W, Herman AG: Inflammatory properties of recombinant tumor necrosis factor in rabbit skin in vivo. J Exp Med. 1989, 169: 2227-2232.PubMed Rampart M, De Smet W, Fiers W, Herman AG: Inflammatory properties of recombinant tumor necrosis factor in rabbit skin in vivo. J Exp Med. 1989, 169: 2227-2232.PubMed
78.
go back to reference Dinarello CA: Interleukin-1. Cytokine Growth Factor Rev. 1997, 8: 253-265.PubMed Dinarello CA: Interleukin-1. Cytokine Growth Factor Rev. 1997, 8: 253-265.PubMed
79.
go back to reference Xu J, Itoh Y, Hayashi H, Takii T, Miyazawa K, Onozaki K: Dihydrotestosterone inhibits interleukin-1alpha or tumor necrosis factor alpha-induced proinflammatory cytokine production via androgen receptor-dependent inhibition of nuclear factor-kappaB activation in rheumatoid fibroblast-like synovial cell line. Biol Pharm Bull. 2011, 34: 1724-1730.PubMed Xu J, Itoh Y, Hayashi H, Takii T, Miyazawa K, Onozaki K: Dihydrotestosterone inhibits interleukin-1alpha or tumor necrosis factor alpha-induced proinflammatory cytokine production via androgen receptor-dependent inhibition of nuclear factor-kappaB activation in rheumatoid fibroblast-like synovial cell line. Biol Pharm Bull. 2011, 34: 1724-1730.PubMed
80.
go back to reference Ahlbom E, Prins GS, Ceccatelli S: Testosterone protects cerebellar granule cells from oxidative stress-induced cell death through a receptor mediated mechanism. Brain Res. 2001, 892: 255-262.PubMed Ahlbom E, Prins GS, Ceccatelli S: Testosterone protects cerebellar granule cells from oxidative stress-induced cell death through a receptor mediated mechanism. Brain Res. 2001, 892: 255-262.PubMed
81.
go back to reference Nguyen TV, Yao M, Pike CJ: Androgens activate mitogen-activated protein kinase signaling: role in neuroprotection. J Neurochem. 2005, 94: 1639-1651.PubMed Nguyen TV, Yao M, Pike CJ: Androgens activate mitogen-activated protein kinase signaling: role in neuroprotection. J Neurochem. 2005, 94: 1639-1651.PubMed
82.
go back to reference De Marinis E, Acaz-Fonseca E, Arevalo MA, Ascenzi P, Fiocchetti M, Marino M, Garcia-Segura LM: 17beta-Oestradiol anti-inflammatory effects in primary astrocytes require oestrogen receptor beta-mediated neuroglobin up-regulation. J Neuroendocrinol. 2013, 25: 260-270.PubMed De Marinis E, Acaz-Fonseca E, Arevalo MA, Ascenzi P, Fiocchetti M, Marino M, Garcia-Segura LM: 17beta-Oestradiol anti-inflammatory effects in primary astrocytes require oestrogen receptor beta-mediated neuroglobin up-regulation. J Neuroendocrinol. 2013, 25: 260-270.PubMed
83.
go back to reference Azcoitia I, Sierra A, Veiga S, Honda S, Harada N, Garcia-Segura LM: Brain aromatase is neuroprotective. J Neurobiol. 2001, 47: 318-329.PubMed Azcoitia I, Sierra A, Veiga S, Honda S, Harada N, Garcia-Segura LM: Brain aromatase is neuroprotective. J Neurobiol. 2001, 47: 318-329.PubMed
84.
go back to reference Nakagawa T, Schwartz JP: Gene expression patterns in in vivo normal adult astrocytes compared with cultured neonatal and normal adult astrocytes. Neurochem Int. 2004, 45: 203-242.PubMed Nakagawa T, Schwartz JP: Gene expression patterns in in vivo normal adult astrocytes compared with cultured neonatal and normal adult astrocytes. Neurochem Int. 2004, 45: 203-242.PubMed
85.
go back to reference Rozovsky I, Finch CE, Morgan TE: Age-related activation of microglia and astrocytes: in vitro studies show persistent phenotypes of aging, increased proliferation, and resistance to down-regulation. Neurobiol Aging. 1998, 19: 97-103.PubMed Rozovsky I, Finch CE, Morgan TE: Age-related activation of microglia and astrocytes: in vitro studies show persistent phenotypes of aging, increased proliferation, and resistance to down-regulation. Neurobiol Aging. 1998, 19: 97-103.PubMed
86.
go back to reference Day JR, Frank AT, O’Callaghan JP, Jones BC, Anderson JE: The effect of age and testosterone on the expression of glial fibrillary acidic protein in the rat cerebellum. Exp Neurol. 1998, 151: 343-346.PubMed Day JR, Frank AT, O’Callaghan JP, Jones BC, Anderson JE: The effect of age and testosterone on the expression of glial fibrillary acidic protein in the rat cerebellum. Exp Neurol. 1998, 151: 343-346.PubMed
87.
go back to reference Pike CJ: Estrogen modulates neuronal Bcl-xL expression and beta-amyloid-induced apoptosis: relevance to Alzheimer’s disease. J Neurochem. 1999, 72: 1552-1563.PubMed Pike CJ: Estrogen modulates neuronal Bcl-xL expression and beta-amyloid-induced apoptosis: relevance to Alzheimer’s disease. J Neurochem. 1999, 72: 1552-1563.PubMed
88.
go back to reference Leranth C, Petnehazy O, MacLusky NJ: Gonadal hormones affect spine synaptic density in the CA1 hippocampal subfield of male rats. J Neurosci. 2003, 23: 1588-1592.PubMed Leranth C, Petnehazy O, MacLusky NJ: Gonadal hormones affect spine synaptic density in the CA1 hippocampal subfield of male rats. J Neurosci. 2003, 23: 1588-1592.PubMed
89.
go back to reference Lustig RH, Pfaff DW, Fishman J: Induction of LH hypersecretion in cyclic rats during the afternoon of oestrus by oestrogen in conjunction with progesterone antagonism or opioidergic blockade. J Endocrinol. 1988, 117: 229-235.PubMed Lustig RH, Pfaff DW, Fishman J: Induction of LH hypersecretion in cyclic rats during the afternoon of oestrus by oestrogen in conjunction with progesterone antagonism or opioidergic blockade. J Endocrinol. 1988, 117: 229-235.PubMed
90.
go back to reference Barth BM, Gustafson SJ, Kuhn TB: Neutral sphingomyelinase activation precedes NADPH oxidase-dependent damage in neurons exposed to the proinflammatory cytokine tumor necrosis factor-alpha. J Neurosci Res. 2012, 90: 229-242.PubMedCentralPubMed Barth BM, Gustafson SJ, Kuhn TB: Neutral sphingomyelinase activation precedes NADPH oxidase-dependent damage in neurons exposed to the proinflammatory cytokine tumor necrosis factor-alpha. J Neurosci Res. 2012, 90: 229-242.PubMedCentralPubMed
91.
go back to reference Wong G, Goldshmit Y, Turnley AM: Interferon-gamma but not TNF alpha promotes neuronal differentiation and neurite outgrowth of murine adult neural stem cells. Exp Neurol. 2004, 187: 171-177.PubMed Wong G, Goldshmit Y, Turnley AM: Interferon-gamma but not TNF alpha promotes neuronal differentiation and neurite outgrowth of murine adult neural stem cells. Exp Neurol. 2004, 187: 171-177.PubMed
92.
go back to reference Neumann H, Schweigreiter R, Yamashita T, Rosenkranz K, Wekerle H, Barde YA: Tumor necrosis factor inhibits neurite outgrowth and branching of hippocampal neurons by a rho-dependent mechanism. J Neurosci. 2002, 22: 854-862.PubMed Neumann H, Schweigreiter R, Yamashita T, Rosenkranz K, Wekerle H, Barde YA: Tumor necrosis factor inhibits neurite outgrowth and branching of hippocampal neurons by a rho-dependent mechanism. J Neurosci. 2002, 22: 854-862.PubMed
93.
go back to reference Mishra A, Kim HJ, Shin AH, Thayer SA: Synapse loss induced by interleukin-1beta requires pre- and post-synaptic mechanisms. J Neuroimmune Pharmacol. 2012, 7: 571-578.PubMedCentralPubMed Mishra A, Kim HJ, Shin AH, Thayer SA: Synapse loss induced by interleukin-1beta requires pre- and post-synaptic mechanisms. J Neuroimmune Pharmacol. 2012, 7: 571-578.PubMedCentralPubMed
94.
go back to reference Zhang K, Xu H, Cao L, Li K, Huang Q: Interleukin-1beta inhibits the differentiation of hippocampal neural precursor cells into serotonergic neurons. Brain Res. 2013, 1490: 193-201.PubMed Zhang K, Xu H, Cao L, Li K, Huang Q: Interleukin-1beta inhibits the differentiation of hippocampal neural precursor cells into serotonergic neurons. Brain Res. 2013, 1490: 193-201.PubMed
95.
go back to reference Obrosova IG: Diabetic painful and insensate neuropathy: pathogenesis and potential treatments. Neurotherapeutics. 2009, 6: 638-647.PubMed Obrosova IG: Diabetic painful and insensate neuropathy: pathogenesis and potential treatments. Neurotherapeutics. 2009, 6: 638-647.PubMed
96.
go back to reference Rowe-Rendleman CL, Eichberg J: P0 phosphorylation in nerves from normal and diabetic rats: role of protein kinase C and turnover of phosphate groups. Neurochem Res. 1994, 19: 1023-1031.PubMed Rowe-Rendleman CL, Eichberg J: P0 phosphorylation in nerves from normal and diabetic rats: role of protein kinase C and turnover of phosphate groups. Neurochem Res. 1994, 19: 1023-1031.PubMed
97.
go back to reference Scarpini E, Bianchi R, Moggio M, Sciacco M, Fiori MG, Scarlato G: Decrease of nerve Na+, K(+)-ATPase activity in the pathogenesis of human diabetic neuropathy. J Neurol Sci. 1993, 120: 159-167.PubMed Scarpini E, Bianchi R, Moggio M, Sciacco M, Fiori MG, Scarlato G: Decrease of nerve Na+, K(+)-ATPase activity in the pathogenesis of human diabetic neuropathy. J Neurol Sci. 1993, 120: 159-167.PubMed
98.
go back to reference Raccah D, Fabreguetts C, Azulay JP, Vague P: Erythrocyte Na(+)-K(+)-ATPase activity, metabolic control, and neuropathy in IDDM patients. Diabetes Care. 1996, 19: 564-568.PubMed Raccah D, Fabreguetts C, Azulay JP, Vague P: Erythrocyte Na(+)-K(+)-ATPase activity, metabolic control, and neuropathy in IDDM patients. Diabetes Care. 1996, 19: 564-568.PubMed
99.
go back to reference Wuarin-Bierman L, Zahnd GR, Kaufmann F, Burcklen L, Adler J: Hyperalgesia in spontaneous and experimental animal models of diabetic neuropathy. Diabetologia. 1987, 30: 653-658.PubMed Wuarin-Bierman L, Zahnd GR, Kaufmann F, Burcklen L, Adler J: Hyperalgesia in spontaneous and experimental animal models of diabetic neuropathy. Diabetologia. 1987, 30: 653-658.PubMed
100.
go back to reference Ohsawa M, Carlsson A, Asato M, Koizumi T, Nakanishi Y, Fransson R, Sandstrom A, Hallberg M, Nyberg F, Kamei J: The effect of substance P1-7 amide on nociceptive threshold in diabetic mice. Peptides. 2011, 32: 93-98.PubMed Ohsawa M, Carlsson A, Asato M, Koizumi T, Nakanishi Y, Fransson R, Sandstrom A, Hallberg M, Nyberg F, Kamei J: The effect of substance P1-7 amide on nociceptive threshold in diabetic mice. Peptides. 2011, 32: 93-98.PubMed
101.
go back to reference McMahon SB, Cafferty WB, Marchand F: Immune and glial cell factors as pain mediators and modulators. Exp Neurol. 2005, 192: 444-462.PubMed McMahon SB, Cafferty WB, Marchand F: Immune and glial cell factors as pain mediators and modulators. Exp Neurol. 2005, 192: 444-462.PubMed
102.
go back to reference Constantin CE, Mair N, Sailer CA, Andratsch M, Xu ZZ, Blumer MJ, Scherbakov N, Davis JB, Bluethmann H, Ji RR, Kress M: Endogenous tumor necrosis factor alpha (TNFalpha) requires TNF receptor type 2 to generate heat hyperalgesia in a mouse cancer model. J Neurosci. 2008, 28: 5072-5081.PubMed Constantin CE, Mair N, Sailer CA, Andratsch M, Xu ZZ, Blumer MJ, Scherbakov N, Davis JB, Bluethmann H, Ji RR, Kress M: Endogenous tumor necrosis factor alpha (TNFalpha) requires TNF receptor type 2 to generate heat hyperalgesia in a mouse cancer model. J Neurosci. 2008, 28: 5072-5081.PubMed
103.
go back to reference Binshtok AM, Wang H, Zimmermann K, Amaya F, Vardeh D, Shi L, Brenner GJ, Ji RR, Bean BP, Woolf CJ, Samad TA: Nociceptors are interleukin-1beta sensors. J Neurosci. 2008, 28: 14062-14073.PubMedCentralPubMed Binshtok AM, Wang H, Zimmermann K, Amaya F, Vardeh D, Shi L, Brenner GJ, Ji RR, Bean BP, Woolf CJ, Samad TA: Nociceptors are interleukin-1beta sensors. J Neurosci. 2008, 28: 14062-14073.PubMedCentralPubMed
Metadata
Title
Diet-induced obesity and low testosterone increase neuroinflammation and impair neural function
Authors
Anusha Jayaraman
Daniella Lent-Schochet
Christian J Pike
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Journal of Neuroinflammation / Issue 1/2014
Electronic ISSN: 1742-2094
DOI
https://doi.org/10.1186/s12974-014-0162-y

Other articles of this Issue 1/2014

Journal of Neuroinflammation 1/2014 Go to the issue